MedTrace Logo

Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema

NCT05918237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-06-26

No results posted yet for this study

Summary

Up to 30 participants with mild to moderate atopic dermatitis/eczema will be enrolled to apply study Investigational Product for 4 weeks.

Conditions

  • Atopic Dermatitis Eczema

Interventions

OTHER

Arctiva

A colloidal oatmeal cream designed to stimulate healing and repair of damaged tissue naturally, working with the body instead of against it.

Sponsors & Collaborators

  • Arctiva Wellness LLC

    collaborator INDUSTRY

  • ClinOhio Research Services, LLC

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-06
Primary Completion
2023-04-28
Completion
2023-04-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05918237 on ClinicalTrials.gov